WhatsApp’s entry into the Payments Arena

        WhatsApp has started rolling out its peer-to-peer payments feature for its users in India. Currently it is in a testing phase and is available to a small number of beta app users only. It is looking forward to provide the customers, seamless messaging as well as the ease of real time money transfer, as the feature is based on the Unified Payments Interface system, which is made by National Payments Corporation of India. UPI allows money transfer directly into bank accounts at zero cost, without any hassles of entering bank account numbers, passwords or pins.  The payments war will intensify as WhatsApp will compete with major players in the payments market such as Paytm, PhonePe, BHIM, Google Tez, etc. This comes after the recently launched WhatsApp Business, an app that allows businesses to manage its customers. It is evident that WhatsApp wants to expand its foray into the business world.

Analysis Report: ITC (Buy, Estimated Price: Rs. 840.36)

About the Company

ITC was incorporated on 24 August 1910 under the name Imperial Tobacco Company of India Limited later on in 1970 company’s ownership was taken to and the name changed to India Tobacco Company Limited and finally in 1974 ITC Limited. ITC has presence in various Industries mainly includes FMCG, Hotel, Agriculture, Tobacco, IT and Retail. However, they took a long journey and also went into backward integration by setting up their packaging business in 1925 also they took their first step to move out of national boundaries by setting a Surya tobacco company in Nepal.

Analysis Report: Lupin Ltd (BUY; Estimated Price: Rs.2740)

About the Company

Lupin Ltd was founded by Dr Desh Bandhu Gupta in 1968 with a vision and dream to fight life threatening infectious diseases and to manufacture drugs of the highest social priority. Itis dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies. Lupin is the 7^th largest pharmaceutical company globally by market capitalization and 10^th largest pharmaceutical company globally by sales.

Analysis Report: Aurobindo Pharma (BUY; Estimated Price: Rs.1076)

About the Company

Aurobindo Pharma Limited is a public pharmaceutical manufacturing organization headquartered in Hyderabad, India. The company fabricates generic pharmaceuticals and active pharmaceutical ingredients. It was established in 1986 by Mr. P. V. Ramaprasad Reddy and Mr. K. Nityananda Reddy. The company initiated operations in 1988-89 with a single unit producing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995.

Analysis Report: TATA ELXSI (BUY; Estimated Price: Rs. 3172)

About the Company

Tata Elxsi founded in 1989 is a design company that blends technology, creativity and engineering to help customers transform ideas into world-class products and solutions.

A part of the $100 billion Tata group, it addresses the communications, consumer products, defence, healthcare, media & entertainment, semiconductor and transportation sectors. This is supported by a network of design studios, development centres and offices worldwide.